| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.2 | 9e-07 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.15 | 9e-06 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.5 | 1e-05 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-05 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.13 | 7e-05 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.16 | 7e-05 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.18 | 0.0002 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.18 | 0.0003 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0004 |